NASDAQ:ACAD | Free Cash Flow | ACADIA PHARMACEUTICALS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2009-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31$33.98M$5.21M$28.77M791.01%
2025-12-31-$48.73M$4.01M-$52.74M-19.28%
2025-03-31$20.32M$0.00$20.32M107.04%
2024-12-31$40.38M$453,000.00$39.93M27.78%
2024-03-31$29.08M
2023-12-31$85.39M$0.00$85.39M186.45%
2023-03-31-$17.93M
2022-12-31-$23.85M$0.00-$23.85M
2022-03-31-$76.33M$0.00-$76.33M
2021-12-31-$23.12M$1,000.00-$23.12M
2021-03-31-$60.15M$1.08M-$61.23M
2020-12-31-$27.49M$2M-$29.49M
2020-03-31-$49M$934,000.00-$49.94M
2019-12-31-$29.71M$207,000.00-$29.91M
2019-03-31-$64.18M$822,000.00-$65M
2018-12-31-$39.08M$526,000.00-$39.61M
2018-03-31-$45.24M$448,000.00-$45.68M
2017-12-31-$29.9M$7,000.00-$29.9M
2017-03-31-$70.56M$485,000.00-$71.05M
2016-12-31-$61.19M$249,000.00-$61.44M
2016-03-31-$41.21M$207,000.00-$41.42M
2015-12-31-$34.72M$293,000.00-$35.02M
2015-03-31-$25.35M$988,000.00-$26.33M
2014-12-31-$17.8M$94,000.00-$17.9M
2014-03-31-$14.18M$6,000.00-$14.19M
2013-12-31-$10.27M$128,000.00-$10.39M
2013-03-31-$6.59M
2012-12-31-$6.3M
2012-03-31-$5.23M
2011-12-31-$5.34M
2011-03-31-$5.11M
2010-12-31$4.6M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31$109.84M$4.69M$105.15M26.89%
2024-12-31$157.72M$523,000.00$157.2M69.42%
2023-12-31$16.7M$50,000.00$16.65M
2022-12-31-$114.04M$0.00-$114.04M
2021-12-31-$125.66M$1.12M-$126.78M
2020-12-31-$136.17M$7.59M-$143.75M
2019-12-31-$151.13M$1.13M-$152.26M
2018-12-31-$167.47M$2.1M-$169.57M
2017-12-31-$217.76M$812,000.00-$218.57M
2016-12-31-$208.41M$1.51M-$209.91M
2015-12-31-$121.8M$2.14M-$123.94M
2014-12-31-$66.43M$180,000.00-$66.61M
2013-12-31-$31.77M$618,000.00-$32.39M
2012-12-31-$21.63M
2011-12-31-$19.9M$3,000.00-$19.9M
2010-12-31-$10.7M
2009-12-31-$13.73M